 First of all, that's wrong. The FDA explained that it looked at multiple studies that encompassed multiple changes at once. But second of all, this is a major reason why folks like the American Cancer Society, the Leukemia and Lymphoma Society, and countless other patient healthcare advocacy groups are sounding the alarm. Because this idea that the FDA needed a single clinical trial to